Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia

NCT00115310 is registered in ClinicalTrials.gov with NeurogesX as lead sponsor.

NCT NCT00115310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00115310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
Lead sponsor
NeurogesX
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2005
Completion date
October 31, 2006
Enrollment
400
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, neuralgia, pain, peripheral nervous system diseases, shingles